Innolake Biopharm
About:
Innolake Biopharm clinical-stage biotech company with a focus on oncology and autoimmune disease areas.
Website: http://www.innolakebio.com/
Top Investors: CDH Investments, Huagai Capital, Zhongbo Juli, Hangzhou Heda Industry Fund, Hangzhou Huaan Jingyin Investment
Description:
Innolake Biopharm clinical-stage biotech company with a focus on oncology and autoimmune disease areas.
Total Funding Amount:
400M CNY
Headquarters Location:
Hangzhou, Zhejiang, China
Founded Date:
2020-01-01
Contact Email:
info(AT)innolakebio.com
Founders:
Number of Employees:
51-100
Last Funding Date:
2023-06-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai